The Apothecary Recalls Sterile Injection Medications Due to Sterility Assurance Concerns
The Apothecary is recalling unexpired lots of sterile injection medications due to unsubstantiated validation of beyond-use dating, which raises concerns about sterility.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II. Per the rubric, FDA Class II recalls involving significant injury/property-damage reports or hospitalization are Severe (4). While the source does not explicitly state hospitalizations, the lack of sterility assurance in injectable medications presents a significant risk of serious adverse health consequences, aligning with the Severe criteria for Class II recalls where the hazard is not merely theoretical or minor.
Plain-English summary
The Apothecary, a compounding pharmacy in Sartell, Minnesota, is recalling unexpired lots of medications containing Calcium Gluconate, Papaverine, Phentolamine, and/or Prostaglandin. The recall is being conducted due to a lack of assurance of sterility resulting from unsubstantiated validation of beyond-use dating.
The affected products are prescription-only sterile injection medications distributed in Minnesota. The recall includes specific lots identified by the codes 06201604@15, 19201602@3, and 06201604@8. The source text does not specify the exact number of units affected or the specific dates of distribution.
Patients who have received these medications should contact their healthcare provider for guidance. The FDA classifies this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Papaverine 75 mg / Phentolamine 2.5 mg / Prostaglandin 25 mcg -- 4.2 mL GLASS VIAL, Rx only, THE APOTHECARY, A COMPOUNDING PHARMACY, 165 19th St S #102, Sartell, MN 56377
- Manufacturer
- W & C dba The Apothecary
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- LOT #: 06201604@15
- 19201602@3
- 06201604@8
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 5 recalled by W & C dba The Apothecary under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · W & C dba The Apothecary
See all →- SevereThe Apothecary Recalls Calcium Gluconate IV Bags Due to Sterility Concerns
FDA (Drugs) · 2016-09-28
- SevereCalcium Gluconate Syringes Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2016-09-28
- SevereThe Apothecary Recalls Sterile Medications Due to Sterility Assurance Issues
FDA (Drugs) · 2016-09-28
- SevereThe Apothecary Recalls Prostaglandin and Other Medications Due to Sterility Concerns
FDA (Drugs) · 2016-09-28
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29